A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants
Clinical trial NCT04840901 · COMPLETED
Trial details
- NCT number
- NCT04840901
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-02
- Primary completion
- 2022-02-11
- Enrollment
- 242
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.